Summary

Along with an increase in obesity and insulin resistance, there has been an increase in the use of concentrated insulin. This article discusses new products and how they will be incorporated into clinical practice, beneficial alternative systems, whether new insulin formulations are meeting these expectations, as well as guidelines and experience with the long-acting insulin analogs in pregnancy.